LC
BMY icon

Lilley & Co’s Bristol-Myers Squibb BMY Stock Holding History

Lilley & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$200K Hold
4,125
– – 0.09% 103
2014
Q1 		$214K Sell
4,125
-75
-2% -$3.99K 0.1% 105
2013
Q4 		$224K Sell
4,200
-175
-4% -$8.91K 0.1% 99
2013
Q3 		$203K Buy
+4,375
New +$192K 0.11% 100

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lilley & Co's BMY Position: Q2 2014 in Review

Lilley & Co held its Bristol-Myers Squibb (BMY) position steady in Q2 2014 at 4,125 shares worth $200K. The position accounts for 0.09% of the portfolio, ranked #103.

Lilley & Co first reported a position in BMY in Q3 2013 and has held it in 4 quarters since. The position peaked at $224K in Q4 2013. 1,301 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Lilley & Co held 4,125 shares of Bristol-Myers Squibb worth $200K as of Q2 2014.
  • Lilley & Co left its Bristol-Myers Squibb share count unchanged in Q2 2014.
  • Bristol-Myers Squibb made up 0.09% of Lilley & Co's portfolio in Q2 2014, its #103 holding.
  • Lilley & Co first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 4 quarters since.
  • Lilley & Co's Bristol-Myers Squibb position peaked at $224K in Q4 2013.
  • 1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Lilley & Co's 13F filing for Q2 2014, filed 14 Jul 2014.